ChemPartner Opens South San Francisco, California, Research Facility
02/03/2015
A service division of the ShangPharma group, ChemPartner, is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. ChemPartner's new research facility will be staffed by experienced drug research scientists from leading biotechnology companies who will collaborate closely with ChemPartner's scientists based in China.
"We are very excited to announce the opening of ChemPartner's new state-of-the-art research facility in South San Francisco, one of the global centers of innovation in life science," said ChemPartner Founder/CEO Michael Hui.
"In drug discovery, scientific excellence is the key to success," Hui continued. "By taking the CRO service business to the next level, this new facility will help enable our customers, partners, and business collaborators to interrogate the most complex of drug discovery projects."
The Company noted that the new facility is the first step in a planned build-out of ChemPartner's research presence in major innovation hubs around the world. "In addition to proximity to the top industry talent, the new facility brings ChemPartner services closer to the biopharmaceutical communities in the United States, and will enable us to develop more innovative ways to bring value to our partners," company officials said.
Project Announcements
SLB Expands Shreveport, Louisiana, Operations
12/18/2025
Eastover Chips Plans Eastover, South Carolina, Wood Chipping Operations
12/18/2025
Eli Lilly and Company Plans Huntsville, Alabama, Manufacturing Operations
12/18/2025
Eccalon Plans Detroit, Michigan, Headquarters Operations
12/18/2025
AECI Utility Solutions Plans Boonville, Missouri, Distribution Operations
12/18/2025
DrinkPak Plans Philadelphia, Pennsylvania, Manufacturing Operations
12/18/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025